Articles related to ALZHEIMER'S/DEMENTIA

Caregiving strategies include validation therapy, early redirection, structured activities, safety modifications, and proactive legal planning to manage dementia progression effectively.

Brain scans reveal sleep apnea patients show imaging patterns resembling early Alzheimer’s disease, suggesting oxygen deprivation creates measurable neurological changes requiring aggressive treatment intervention.

Blood biomarker testing offers 91.7% accuracy in detecting amyloid plaques while providing more accessible alternative to cerebrospinal fluid analysis, though confirmation via PET or CSF remains necessary for indeterminate results.

Treatment with gantenerumab for approximately eight years reduced the risk of developing symptoms from essentially 100% to about 50% in participants with genetic mutations causing early-onset Alzheimer’s.

Deferiprone treatment resulted in significantly accelerated cognitive decline compared to placebo, with a composite z score change of -0.80 versus -0.30, suggesting iron reduction may be detrimental in AD patients.

Antimicrobials, vaccines, and NSAIDs showed promising associations with reduced dementia risk in a comprehensive analysis of over 1 million dementia cases.